MedTrace Logo

Effect of Some Drugs on Rheumatoid Arithritis Activity

NCT03770923 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2018-12-10

No results posted yet for this study

Summary

Effect of Some Drugs on Rheumatoid Arithritis Activity.

Conditions

Interventions

DRUG

Rupatadine

Rupatadine 10 mg daily

DRUG

Montelukast

Montelukast 10 mg daily

Sponsors & Collaborators

  • Sherief Abd-Elsalam

    lead OTHER

Principal Investigators

  • Sahar k Hegazy, Prof · Head of Clinical Pharmacy Department

  • Tarek M Mostafa, Prof · Clinical pharmacy Department- Tanta University

  • Salwa E Abd El-Ghany, Prof · Rheumatology Dept. - Tanta University

  • Fedaa AK Kotkata, Msc · Clinical pharmacy Department-Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2026-10-31
Completion
2027-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03770923 on ClinicalTrials.gov